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higher scores for chronic inﬂammation compared to those
with dupA-negative strains (2.36 vs. 2.24, p = 0.058). The
presence of dupA was not associated with the cagA, vacA,
iceA or babA 2 genotypes.
Conclusions: In Shanghai the prevalence of dupA gene was
highest in DU and inversely related to GU and gastric cancer
both which are associated with corpus atrophy.
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In order to categorise a bacterium as sensitive to
an antibiotic, it is necessary to perform a phenotypic
antimicrobial susceptibility test. Phenotypic AST systems
need breakpoints to. categorise bacteria S, I or R.
Breakpoints are best determined by breakpoint committees
consisting of experts in the ﬁelds of clinical microbiology
and infectious diseases. Both CLSI (formerly NCCLS
in the USA) and EUCAST (the European Committee
on Antimicrobial Susceptibility Testing) are well known
breakpoint committees. The former is a commercial
enterprise engaging the pharmaceutical industry and
the profession whereas the EUCAST is organised by
the European Centre for Disease Control, the European
Medicines Evaluation Agency and the European Society for
Clinical Microbiology and Infectious Diseases. EUCAST has
harmonised breakpoints for Europe and acts as the EMEA
breakpoint committee during the process of approval of
new drugs.
EUCAST breakpoints are currently being introduced in
automated systems for AST. The Phoenix from Becton
Dickinson is already validated with EUCAST breakpoints and
the Vitek2 from BioMerieux is to follow. A disk test based on
Mueller Hinton agar and 108 cfu/mL inoculum is currently
being developed by EUCAST.
New therapeutic traditions, dosage practices, new tools for
setting breakpoints and most importantly new resistance
mechanisms necessitates an evolutionary process for clinical
breakpoints. EUCAST has an active process for reviewing and
revising breakpoints.
EUCAST offers free documents on breakpoints, methods
and interpretive criteria on its website (www.eucast.org)
which also displays MIC- (and eventually zone diameter-)
distributions of wild type bacteria on the website. These
can be used for calibration of methods.
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Despite extensive investigations, a microbiological cause
cannot be found in about half of the patients with infectious
disease. Throughout the years, scientists have spent
tremendous efforts in looking for microorganisms associated
with these “unexplained infectious disease syndromes”. In
2001, we discovered Laribacter hongkongensis gen. nov.
sp. nov., a facultative anaerobic, Gram-negative, S-shaped,
urease-positive rod of the Neisseriaceae family, from blood
and empyema thoracis of a patient with alcoholic cirrhosis.
During the past seven years, we have documented that
L. hongkongensis was associated with gastroenteritis and
traveler’s diarrhea and cases were found globally in patients
who resided in or had recent travel histories to countries
in Asia, Europe, America and Africa. We have found that
freshwater ﬁsh is the reservoir and it was also found
in drinking water reservoirs. We have cloned the beta-
lactamase and tetracycline resistance genes and developed
gene deletion and expression systems for L. hongkongensis.
Due to the potential of its clinical importance and
related ecology, important phenotypic characteristics and
phylogenetic position, and the availability of genetic
manipulation systems for downstream experiments, we
sequenced the complete genome of L. hongkongensis, with
the aim of achieving better understanding of its biology,
mechanism of adaptation to different hosts, and virulence
mechanisms.
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While resistant gram-positive pathogens such as MRSA and
VRE have received a lot of attention especially in the US and
Europe, there have been rising numbers of multi-resistant
and even pan-drug resistant strains of gram-negative bacilli
in particular Pseudomonas and Acinetobacter spp. These
have posed tremendous challenges to the clinicians looking
after patients especially in Asia and Southern Europe. With
limited therapeutic options, a greater focus on prevention
and control has resulted. We are also hampered by a lack of
good data to explain the emergence of these pathogens and
to understand the reasons for their spread to our vulnerable
patients.
I-20 Two stage theory pathogenic mechanism of
Streptococcus suis
J. Xu, H. Zheng, C. Ye, H. Jing. State Key Laboratory
for Infectious Disease Prevention and Control, and
National Institute for Communicable Disease Control and
Prevention, China
Streptococcus suis infections are enzootic in pigs where
sporadic cases occur in humans. Since the ﬁrst human case
was recorded in 1968, only 250 cases have been reported
globally through June 2005. The majority of the cases have
resulted in meningitis often associated with hearing loss.
During the period from July to August 2005, however, an
explosive outbreak of 215 cases of human infection occurred
in Sichuan Province, China. Sixty-one of the 215 (28%)
patients presented an unusual streptococcal toxic shock
like syndrome (STSLS) with high mortality (38 of 61; 62%) in
previously healthy farmers. Both the clinical presentation
and epidemiology features of the Sichuan outbreak had not
previously been observed.
This outbreak was caused by a mutant S. suis named
as sequence type 7 (ST7) using the multi-locus sequence
typing method, the method of choice for addressing
questions related to genotyping for epidemiological studies,
population, and evolutionary biology. The ST7 strain caused
a single case described from Hong Kong in 1996; then it
emerged to cause a small outbreak in Jiangsu in 1998; and
spread to cause the largest ever outbreak with severe shock
in 2005.
It was found that the serum levels of IL-1b, IL-6, IL-8, IL-12,
p70, IFN-g and TNF-a, the inﬂammation cytokines, during
the early phase of the disease were signiﬁcantly elevated in
patients with STSLS compared to those with meningitis only.
And, the serum levels of pro-inﬂammatory cytokines were
signiﬁcantly higher in mice infected with the ST7 strain than
in those infected with either the ST1 or ST25 strains.
Genome comparisons showed the ST1 strain had acquired
132 genomic islands, including 5 pathogenicity islands, and
the “epidemic” strain ST7 had acquired an additional 5
genomic islands. Therefore, We proposed the intermediate
virulent ST25 type evolved to become the highly pathogenic
